[Treatment of patients with acute myocardial infarction in a typical clinical practice].
Glezer
M G
MG
Sementsov
D P
DP
Sobolev
K E
KE
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D003331:Coronary Vessels / Q000187:drug effects; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects; D017052:Hospital Mortality; D006773:Hospitals, Municipal / Q000706:statistics & numerical data; D006784:Hospitals, Teaching / Q000706:statistics & numerical data; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000401:mortality* / Q000503:physiopathology; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D012426:Russia / Q000453:epidemiology; D015912:Thrombolytic Therapy / Q000379:methods; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors